#China #Hangzhou #IROS 2025 #Healinno Tech #Prostate Biopsy

Healinno Tech's Revolutionary Biopsy Robot at IROS 2025

In an impressive showcase at the IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2025) held in Hangzhou, China, Healinno Tech (Beijing) Co., Ltd. introduced its cutting-edge hybrid robot aimed at enhancing the accuracy of transperineal prostate biopsies. The event attracted over 7,000 professionals from the robotics and healthcare sectors, laying the groundwork for forward-thinking discussions in medical technology.

Features of the Hybrid Robot

The pioneering robot demonstrates a unique serial-parallel hybrid design, allowing it to offer five degrees of freedom. This design not only enhances the precision of needle insertion but also provides the flexibility needed for various clinical scenarios. The robot's configuration includes two series manipulators, a linear feeding unit, and a positioning mechanism for the ultrasound probe. Such versatility is essential for adapting to the diverse requirements of prostate biopsy procedures.

Tackling Precision Issues

One of the significant challenges in prostate biopsies is ensuring consistent precision during manual procedures. The introduced robot aims to address these obstacles by utilizing an innovative Quantum-behaved Particle Swarm Optimization (QPSO) algorithm. This cutting-edge algorithm optimizes the robotic parameters, significantly improving surgical precision compared to traditional optimization methods. Clinical requirements for high precision are vital for the effectiveness and safety of biopsies, making this advancement crucial.

Experimental Validation

Validation of the robot's capabilities has been conducted through experiments using water and gelatin phantoms. The results were impressive, showcasing an absolute positioning error of merely 1.47 mm in water and 1.75 mm in gelatin, both well within clinical standards. These experiments affirm the robot's reliability and its potential to significantly improve biopsy outcomes.

Future Developments

Continued research and development efforts by Healinno Tech focus on augmenting the robot’s functionalities further. Future features may include dynamic tracking and respiratory compensation to enhance procedure effectiveness. Such advancements pave the way for broader clinical and industrial applications of the robot, marking a turning point in robotic surgical technology.

Conclusion

Healinno Tech's unveiling of this hybrid ultrasound-guided robot at IROS 2025 signifies a monumental step in the evolution of medical robotics. As the technology continues to evolve, we anticipate its transformative impact on prostate biopsy procedures and beyond, illustrating the exciting future ahead for robotics in medicine.